Terminal
Stocks
Spotlight
Research

Stocks
Healthcare
NASDAQ
BGMS

Market Cap: $4.81M

BI

Bio Green Med Solution, Inc.

BGMS

NASDAQ (NASDAQ Global Market)USD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Advertisers Brokers Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin19.34%

EBITDA Margin-1.47%

EBIT Margin-1.47%

Pre-tax Margin-1.16%

Net Profit Margin-1.18%

Earnings Yield-45.08%

Valuation Multiples

Price / Book0.68

Price / Sales2.59

Price / Earnings-0.24

PEG-0.00

Forward PEG0.00

EV / Sales0.55

EV / EBITDA-0.37

EV / Operating Cash Flow-0.93

EV / Free Cash Flow-0.93

Price / Free Cash Flow-4.38

Price / Operating Cash Flow-4.45

Cash Flow & Capital

Free Cash Flow / Share-$0.2

Operating Cash Flow / Share-$0.2

Free Cash Flow Yield-22.81%

Capex / Revenue0.05%

Capex / Operating Cash Flow-0.09%

Capex / Depreciation0.20

Stock Compensation / Revenue35.57%

Dividend Payout Ratio-2.77%

Dividend Yield0.00%

Liquidity & Leverage

Current Ratio8.63

Quick Ratio7.22

Cash Ratio5.48

Debt / Assets0.00

Debt / Capital0.00

Debt / Equity0.00

Long-Term Debt / Capital0.00

Debt / Market Cap0.00%

Net Debt / EBITDA1.39

Solvency Ratio-3.16

Financial Leverage1.10

Efficiency & Working Capital

Asset Turnover0.24

Fixed Asset Turnover13.01

Inventory Turnover1.54

Receivables Turnover1.73

Payables Turnover7.94

Days Sales Outstanding210.64

Days Inventory Outstanding236.36

Days Payables Outstanding45.96

Operating Cycle447.01

Cash Conversion Cycle401.05

Working Capital Turnover0.37

Returns & Quality

Return on Equity-31.60%

Return on Assets-28.02%

Return on Invested Capital-38.23%

ROCE-38.23%

Return on Tangible Assets-35.03%

Operating Return on Assets-35.52%

Income Quality0.50

Tax Burden1.02

Interest Burden0.79

Balance Sheet & Intrinsic Metrics

Enterprise Value$1.02M

Invested Capital$6.99M

Working Capital$5.28M

Tangible Asset Value$5.59M

Net Current Asset Value$5.28M

Graham Net-Net$0.78

Book Value / Share$1.28

Tangible Book Value / Share$1

Cash / Share$0.68

Financial Health Scores

Piotroski Score4

Altman Z-Score-77.15

Revenue$1.86M

EBIT$-2.74M

Market Cap$4.7M

Working Capital$5.28M

Retained Earnings$-455.01M

Total Assets$7.85M

Total Liabilities$694K